资讯
The topic selection oversight panel is mainly responsible for making the following decisions about topics that have been considered by the NICE team: selecting devices, diagnostics and digital health ...
TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807] Medicine Not selected TBC Sulthiame for treating self-limiting epilepsy with centrotemporal ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果